The Mumps Virus Neurovirulence Safety Test in Rhesus Monkeys: A Comparison of Mumps Virus Strains

Wild type mumps viruses are highly neurotropic and a frequent cause of aseptic meningitis in unvaccinated humans. To test whether attenuated mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey neurovirulence safety test (MNVT) is performed. However, result...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 180; no. 2; pp. 521 - 525
Main Authors Rubin, Steven A., Snoy, Philip J., Wright, Kathryn E., Brown, Earl G., Reeve, Peter, Beeler, Judy A., Carbone, Kathryn M.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.08.1999
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Wild type mumps viruses are highly neurotropic and a frequent cause of aseptic meningitis in unvaccinated humans. To test whether attenuated mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey neurovirulence safety test (MNVT) is performed. However, results with several mumps virus MNVTs have raised questions as to whether the test can reliably discriminate neurovirulent from nonneurovirulent mumps virus strains. Here, various mumps virus strains representing a wide range of neuropathogenicity were tested in a standardized MNVT. A trend of higher neurovirulence scores was observed in monkeys inoculated with wild type mumps virus versus vaccine strains, although differences were not statistically significant. Results indicated the need for further examination and refinement of the MNVT or for development of alternative MNVTs.
Bibliography:istex:525FD7CFFF282824CECAE221FB53ADD3432755DF
ark:/67375/HXZ-2RRQ9P85-V
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1086/314905